Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients).
The ideal partner for custom synthesis and contract manufacturing projects.


Olon on Pharma Horizon Magazine

October 2017
Not just a telling story... Click the image to read the full article
June 9th, 2017 - OLON acquired RICERCA

OLON SPA (P&R Group) ACQUIRES RICERCA BIOSCIENCES CHEMICAL DIVISION IN OHIO (USA)Acquisition strengthens service offering of global CDMO and Gener...
CPhI Worldwide – Visit us at Booth # 80G51

Frankfurt, 24-26 October 2017
If you need information, speak to one our experts.


Recombinant peptides

Olon has developed a recombinant peptide technology that allows to provide its customers with requested peptide on any scale.

Fluorination: a new technology

Olon with its brand new R&D Labs and Reactors for fluorination can now offer a full range of fluorinating processes under cGMP.